Pécs, Hungary

Balázs Sumegi

This inventor holds 1 USPTO granted patent. Top assignee: N-Gene Research Laboratories, Inc.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Balázs Sumegi. Retrieved from https://idiyas.com/inventor/balandaacutezs-sumegi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Balázs Sumegi: Innovator in Antitumor Pharmaceutical Composition

Introduction

Balázs Sumegi is a notable inventor based in Pécs, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that enhance antitumor activity while minimizing side effects. His work is crucial in the ongoing battle against cancer, providing new avenues for treatment.

Latest Patents

Sumegi holds a patent for a pharmaceutical composition that combines an antitumor agent with a hydroximic acid derivative. This innovative formulation aims to improve the efficacy of cancer treatments while reducing the adverse effects commonly associated with such therapies. His patent is a testament to his dedication to advancing medical science and improving patient outcomes. He has 1 patent to his name.

Career Highlights

Balázs Sumegi is affiliated with N-Gene Research Laboratories, Inc., where he continues to work on groundbreaking research in the pharmaceutical sector. His role at the company allows him to collaborate with other experts in the field, further enhancing the impact of his inventions.

Conclusion

Balázs Sumegi's contributions to pharmaceutical innovation, particularly in antitumor therapies, highlight his commitment to improving cancer treatment. His work exemplifies the importance of research and development in the medical field, paving the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…